Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 1, 2026, American Healthcare REIT, Inc. (AHR) has a Wall Street consensus price target of $50.43, based on estimates from 11 covering analysts. With the stock currently trading at $52.24, this represents a potential downside of -3.5%. The company has a market capitalization of $8.93B.
Analyst price targets range from a low of $43.00 to a high of $55.00, representing a 24% spread in expectations. The median target of $51.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AHR trades at a trailing P/E of -180.1x and forward P/E of 75.3x. Analysts expect EPS to grow +314.7% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how AHR stacks up against sector leader Welltower Inc..
Start ComparisonWall Street's consensus price target for AHR is $50.43, -3.5% from its current price of $52.24. The below-market target from 11 analysts suggests limited near-term appreciation.
AHR has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $50.43 implies -3.5% downside from current levels.
At a forward P/E of 75.2955x, AHR trades at a premium valuation. The consensus price target of $50.43 (-3.5% downside) suggests analysts may view current valuations as stretched.
The most bullish Wall Street analyst has a price target of $55 for AHR, while the most conservative target is $43. The consensus of $50.43 represents the median expectation. These targets typically reflect 12-month expectations.
AHR is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AHR stock forecast based on 11 Wall Street analysts shows a consensus price target of $50.43, with estimates ranging from $43 (bear case) to $55 (bull case). The median consensus rating is "Buy".
AHR trades at a forward P/E ratio of 75.3x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on AHR, with 0 Sell ratings and a price target of $50.43 (-3.5% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AHR analyst price targets range from $43 to $55, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $50.43 consensus represents the middle ground.